An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Part of paid clinical trials in Garden Grove, California.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT07543120
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Hypertension (HTN)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- QCZ484 — DRUGQCZ484 subcutaneous injection, Q6M.
Study Details
The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.
Key Dates
- Start date
- May 7, 2026
- Status verified
- May 2026
- Primary completion
- May 31, 2031
- Completion
- Nov 30, 2031
Study Design
- Enrollment
- 323 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: QCZ484QCZ484 administered subcutaneously (SC) Q6M
Primary Outcome Measure
Number of participants with AEs [ Time Frame: Up to 66 months ]
Central Contacts
- Novartis Pharmaceuticals1-888-669-6682
- Novartis Pharmaceuticals+41613241111
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NICRs Research Center | Garden Grove | California | 92844 | Mallu Reddy. (PRINCIPAL_INVESTIGATOR) |
| Entrust Clinical Research | Miami | Florida | 33176 | Mariuchi Mayon Adolfo Cueli (PRINCIPAL_INVESTIGATOR) |
| Inpatient Research Clinical LLC | Miami Lakes | Florida | 33014 | Alexis Gutierrez. (PRINCIPAL_INVESTIGATOR) |
| Javara Research | Fayetteville | Georgia | 30214 | William Cooper. (PRINCIPAL_INVESTIGATOR) |
| Anderson Medical Research | Ft. Washington | Maryland | 20744 | Ann-Marie Cobb Felton Anderson. (PRINCIPAL_INVESTIGATOR) |
| Monroe Biomedical Research | Monroe | North Carolina | 28112 | Awawu Igbinadolor (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Garden Grove, CA
Related Studies
- Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)Recruiting · Biobeat Technologies Ltd. · Birmingham, Alabama
- A Prospective Registry Study of Patients With HypertensionNot Yet Recruiting · Vivek Bhalla · Palo Alto, California
- Out-of-office Monitoring for Rhythms Of Normal Versus Atrial FibrillationEnrolling By Invitation · University of California, San Francisco · San Francisco, California
- Low Energy Availability and Hypertension in Division I HBCU AthletesRecruiting · North Carolina Agriculture & Technical State University · Greensboro, North Carolina